People · Operator
Named in public records as an officer, director or promoter · active 2024–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Amend Surgical, Inc. | — | Biotechnology | Seed | $2.3M | $5.2M | 2024 |
James F. Kirk at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James F. Kirk on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Lane | 1 | 2 |
| Ronald R. Cobb | 1 | 1 |
| Gary R. Ascani | 1 | 1 |
| Leslie R. Molony | 1 | 1 |
| Wade F. Pilling | 1 | 1 |
| Michael R. Orrico | 1 | 1 |
| Michael Orrico | 1 | 1 |
| Leslie Molony | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.